Core Viewpoint - Prestige Consumer Healthcare (PBH) has been upgraded to a Zacks Rank 2 (Buy), indicating an upward trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system reflects changes in earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - Rising earnings estimates for Prestige Consumer Healthcare suggest an improvement in the company's underlying business, likely leading to higher stock prices [5]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 (Strong Buy) stocks historically generating an average annual return of +25% since 1988 [7]. - The upgrade of Prestige Consumer Healthcare to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns [10]. Earnings Estimate Revisions - Analysts have raised their earnings estimates for Prestige Consumer Healthcare, with the Zacks Consensus Estimate for the fiscal year ending March 2026 projected at $4.55 per share, showing a 0.7% increase over the past three months [8].

Core Viewpoint - Steris (STE) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based on changes in earnings estimates, which are closely correlated with near-term stock price movements, making it a valuable tool for investors [2][4]. - The recent upgrade for Steris reflects an optimistic earnings outlook that could lead to increased buying pressure and a rise in stock price [3][5]. Earnings Estimate Revisions - Steris is projected to earn $10.23 per share for the fiscal year ending March 2026, showing no year-over-year change, but the Zacks Consensus Estimate has increased by 1.7% over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks which have averaged a +25% annual return since 1988 [7]. - Steris's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].

Core Viewpoint - Stagwell (STGW) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - An increase in earnings estimates typically leads to higher fair value for a stock, prompting institutional investors to buy or sell, thus affecting stock prices [4]. Company Performance Indicators - For the fiscal year ending December 2025, Stagwell is expected to earn $0.82 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 4.8% over the past three months [8]. - The upgrade to Zacks Rank 2 places Stagwell in the top 20% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term [10]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a proven track record of Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [7]. - The system maintains a balanced distribution of "buy" and "sell" ratings, ensuring that only the top 5% of stocks receive a "Strong Buy" rating [9].

Core Viewpoint - First Industrial Realty Trust (FR) has received an upgrade to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of changing earnings estimates, which are closely correlated with near-term stock price movements [4][6]. - Institutional investors often rely on earnings estimates to determine the fair value of stocks, leading to buying or selling actions that affect stock prices [4]. Company Performance and Outlook - The upgrade for First Industrial Realty Trust indicates an improvement in the company's underlying business, which is expected to drive stock appreciation [5]. - The Zacks Consensus Estimate for First Industrial Realty Trust is projected at $2.94 per share for the fiscal year ending December 2025, reflecting no year-over-year change, but estimates have increased by 0.7% over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with only the top 20% receiving a "Strong Buy" or "Buy" rating, indicating superior earnings estimate revisions [9][10]. - The upgrade of First Industrial Realty Trust to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term [10].

Core Viewpoint - Atmos Energy (ATO) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][2]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements [3]. - Institutional investors utilize earnings estimates to determine the fair value of stocks, leading to buying or selling actions that affect stock prices [3]. Business Improvement Indicators - The upgrade in ratings and rising earnings estimates suggest an improvement in Atmos Energy's underlying business, which could lead to higher stock prices as investors respond positively [4]. Importance of Earnings Estimate Revisions - Tracking earnings estimate revisions is crucial for investment decisions, and the Zacks Rank system effectively leverages this information [5]. - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance of Zacks Rank 1 stocks averaging a +25% annual return since 1988 [6]. Specific Earnings Estimates for Atmos - For the fiscal year ending September 2026, Atmos Energy is expected to earn $8.02 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 2.7% over the past three months [7]. Zacks Rating System Overview - The Zacks rating system maintains a balanced distribution of "buy" and "sell" ratings across over 4,000 stocks, with only the top 20% receiving a "Strong Buy" or "Buy" rating [8][9]. - Atmos Energy's upgrade to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [9].

Core Viewpoint - PagerDuty (PD) shares have increased by 12% over the past four weeks, closing at $13.04, with a mean price target of $16.75 indicating a potential upside of 28.5% [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $2.82, where the lowest estimate is $12.00 (indicating an 8% decline) and the highest is $20.00 (indicating a 53.4% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Optimism - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 71.7%, with three estimates moving higher and no negative revisions [12] - PagerDuty holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on price targets for investment decisions may not be wise, as empirical research indicates that they often mislead investors [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Ulta Beauty (ULTA), and highlights the potential misalignment of interests between brokerage analysts and retail investors [1][5]. Brokerage Recommendations - Ulta currently has an average brokerage recommendation (ABR) of 1.94, indicating a position between Strong Buy and Buy, based on recommendations from 25 brokerage firms [2]. - Of the 25 recommendations, 13 are Strong Buy (52%) and 2 are Buy (8%) [2]. Limitations of Brokerage Recommendations - Solely relying on brokerage recommendations for investment decisions may not be advisable, as studies indicate they often fail to guide investors effectively towards stocks with high price appreciation potential [5]. - Analysts from brokerage firms tend to exhibit a strong positive bias in their ratings, issuing five "Strong Buy" recommendations for every "Strong Sell" [6][11]. Zacks Rank as an Alternative - Zacks Rank, a proprietary stock rating tool, categorizes stocks from 1 (Strong Buy) to 5 (Strong Sell) and is based on earnings estimate revisions, which are strongly correlated with near-term stock price movements [8][12]. - The Zacks Rank is updated more frequently than the ABR, making it a more timely indicator for predicting future stock prices [13]. Current Earnings Estimates for Ulta - The Zacks Consensus Estimate for Ulta has increased by 4.6% over the past month to $25.51, reflecting analysts' growing optimism about the company's earnings prospects [14]. - This increase in consensus estimates has contributed to a Zacks Rank 2 (Buy) for Ulta, suggesting a positive outlook for the stock [15].

Core Viewpoint - Actuate Therapeutics, Inc. (ACTU) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][4]. Earnings Estimates and Revisions - The Zacks rating system focuses on the consensus measure of EPS estimates from sell-side analysts, which reflects the changing earnings picture of a company [2]. - The Zacks Consensus Estimate for Actuate Therapeutics is projected at -$1.10 per share for the fiscal year ending December 2025, showing no year-over-year change, but estimates have increased by 0.9% over the past three months [9]. Impact of Institutional Investors - Changes in earnings estimates are strongly correlated with stock price movements, influenced by institutional investors who adjust their valuations based on these estimates [5]. - Institutional investors' actions, driven by earnings revisions, lead to significant price movements in stocks [5]. Business Outlook - The upgrade in Zacks Rank for Actuate Therapeutics suggests an improvement in the company's underlying business, which could lead to higher stock prices as investors respond positively to this trend [6][11]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a proven track record of generating significant returns, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [8]. - Actuate Therapeutics' upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating strong potential for market-beating returns in the near term [10][11].

Core Viewpoint - NextNav Inc. (NN) has been upgraded to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1] Group 1: Earnings Estimates and Stock Ratings - The Zacks rating system is based on the consensus measure of EPS estimates from sell-side analysts, reflecting the company's changing earnings picture [1] - The upgrade for Spartacus Acquisition indicates a positive earnings outlook, likely leading to increased buying pressure and a rise in stock price [3] - Rising earnings estimates correlate strongly with stock price movements, influenced by institutional investors who adjust their valuations based on these estimates [4] Group 2: Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly Zacks Rank 1 stocks averaging a +25% annual return since 1988 [7] - The Zacks rating system maintains a balanced distribution of "buy" and "sell" ratings across over 4,000 stocks, ensuring that only the top 20% receive a "Strong Buy" or "Buy" rating [9][10] - Spartacus Acquisition's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10] Group 3: Earnings Estimate Revisions - Spartacus Acquisition is projected to earn -$1.00 per share for the fiscal year ending December 2025, with no year-over-year change [8] - Over the past three months, the Zacks Consensus Estimate for Spartacus Acquisition has increased by 29.7%, reflecting a positive trend in earnings estimates [8]

Core Viewpoint - Pan American Silver (PAAS) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][4]. Earnings Estimates and Ratings - The Zacks rating system is solely based on a company's changing earnings picture, tracking the Zacks Consensus Estimate for EPS from sell-side analysts [2]. - The Zacks rating upgrade for Pan American Silver reflects an improvement in its earnings outlook, which is expected to positively impact its stock price [4][6]. Impact of Earnings Estimates on Stock Prices - Changes in a company's future earnings potential, as indicated by earnings estimate revisions, are strongly correlated with near-term stock price movements, particularly due to institutional investors' reliance on these estimates for valuation [5]. - Rising earnings estimates for Pan American Silver suggest an improvement in the company's underlying business, which should lead to higher stock prices as investors respond positively [6]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [8]. - The upgrade of Pan American Silver to Zacks Rank 1 places it in the top 5% of Zacks-covered stocks, indicating strong potential for market-beating returns in the near term [10][11]. Earnings Estimate Revisions - For the fiscal year ending December 2025, Pan American Silver is expected to earn $2.21 per share, with a 12.8% increase in the Zacks Consensus Estimate over the past three months [9].